Australian flavour and ingredient company The Product Makers (TPM) has reported that its polyphenol rich sugarcane extract may protect against oxidative stress, inflammation and neurological degeneration.
Immune, digestive, cognitive health concerns have been listed as the key drivers in the development of new infant formula products – according to two industry experts.
An Australian-based start-up MyVi has developed a system to create customised beverages according to the real-time needs of an individual’s vitamin requirements through the use of electroacupuncture.
Australian brand Bioclinic Naturals has launched a range of ‘scobiotics’ – consisting prebiotics, probiotics, yeast, spirulina and enzymes – designed to address gastrointestinal problems ranging from inflammation to bringing homeostasis in the gut microflora.
Australia’s Therapeutic Goods Administration (TGA) will conduct compliance checks on listed medicines that are based on TCM, Ayurveda or other traditional paradigms, with firms urged to re-evaluate their products.
Australia-based Fiji Kava is selling its new sleep and relax range of kava supplements for the first time globally, with domestic supermarket chain Coles being the first to stock the products.
An analysis of 115 plant-based milk sold in Australia showed that the category is lacking in several micronutrients, including vitamin A, B12, calcium, and protein when compared to cow’s milk.
Eight in 10 optometrists in Australia and New Zealand have recommended omega-3 dietary supplements or foods rich in the fatty acid to their patients suffering from eye conditions.
Orange juice may be a potential non‐dairy based carrier for the probiotic Lactobacillus sanfranciscensis, according to a study conducted by researchers in Australia.
Australian food and beverage companies making the shift to or adding e-commerce platforms to their businesses must carefully manage any new risk profiles – or run the risk of cyber attacks similar to those recently experienced by the country’s largest...
Australian e-commerce platform BuyNatural believes there are “exceptional opportunities” in China for local dietary supplement brands, with consumers eager to purchase “newer and smaller” brands.
Singapore biotech outfit iX Biopharma is expanding its Australian-based nutraceutical division, Entity Health, with new products and functions using its patented drug delivery system, WaferiX.
The probiotic supplement industry has slammed an online beer advertisement for capitalising on therapeutic terms such as ‘pro-biotic’ and ‘good for the gut’ which were permitted for being only “tongue-in-cheek” by an alcohol marketing regulator.
Australia’s complementary medicines sector continues to surge, with the sector officially valued at AUD$5.6bn last year (US$3.9bn), up from AUD$5.2bn (US$3.5bn) in 2018, while exports grew by another 15% to AUD$1.1bn (US$766m).
In this round-up, we look at new developments from both big and local brands, such as Australia's Jatenergy's launch of lactoferrin-enriched milk powder, Swisse's plans to roll out supplements with upcycled grape seed extract, and Dabur...
Jatenergy has developed two new lactoferrin-enriched milk powder products as market interest in immune-strengthening functional foods continue to grow amid COVID-19.
CBD specialist Elixinol Global has managed to hit its capital raising target of AUD$11m (US$7.3m) following a two-stage fund raising exercise, which it believes is a proof of how its CBD supplements have resonated with its investors.
Blackmores has published a new whitepaper on nutrition guidelines for strengthening the immune system, preventing and treating respiratory tract infections – designed specifically for pharmacists.
Health and wellness powerhouse Swisse plans to roll out dietary supplements and skincare products containing upcycled grape seed extract derived from Australia’s wine-producing industry.
Australian supplements giant Blackmores is tapping investors for AUD117m (US$78m) to help drive its expansion in Asia – although the firm’s largest shareholder Marcus Blackmore won’t be among those dipping into his pocket.
Australia’s Renovatio Bioscience has developed a new product that claims to strengthen the immune system using a combination of activated phenolics, quercetin, and sunflower extract.
A report from Australian regulator the Therapeutic Goods Administration (TGA) found that the percentage of health supplements that breached regulatory compliances in the second half of last year was less than that of 2018.
Industry leaders in Australia have hailed cross-party agreement that will lead to five years protection for clinical trials for complementary medicines and supplements, a world-first move that trade body Complementary Medicines Australia (CMA) says will...
Australian regulator, the Therapeutic Goods Administration (TGA) is reviewing recent reported cases of vitamin B6 intake and the possible side effect of peripheral neuropathy.
The body’s absorption of palmitoylethanolamide (PEA) – a healthy fatty acid – could be increased by 1.75 times using a novel dispersion technology, a human clinical trial has demonstrated.
Australian-based Homart Pharmaceuticals is launching three vitamin C products under the Toplife and Springleaf brands to tap on rising demand for immune-related products during the COVID-19 pandemic.
Cannabidiol (CBD) and tetrahydrocannabinol (THC) are increasingly gaining traction and are said to hold “great promise” for managing chronic pain, claims a leading Australian researcher who stars in our seventh NutraChampion podcast.
Australia’s e-commerce platform BuyNatural is working with local olive leaf specialist Wellgrove Health on a range of immunity-boosting supplements for the domestic and China markets to meet increased demand.
Supplements containing cannabidiol (CBD) should be made available in health foods stores in Australia, trade body Complementary Medicines Australia (CMA) has said as the country’s regulator reviews existing rules.
As the two countries engage in an increasingly hostile war of words over the COVID-19 outbreak, could the Australian supplement industry’s huge export success to China now be under threat? Editor-in-Chief Gary Scattergood assesses the risk of collateral...
Australia’s Fight Food Waste Cooperative Research Centre (CRC) has launched a project to transform waste potato into higher value products in a bid to reduce food waste and increase profitability.
Swisse says that its newly introduced hemp-based supplements and skincare range in the Australian market will play a crucial role in driving incremental growth for this year.
A curcumin and artemisinin-based oral spray has been proposed as a treatment for COVID-19 patients and a clinical trial will be conducted, ASX-listed phytocannabinoid firm MGC Pharmaceuticals has revealed.
Optibiotix says sales of its flagship weight management product, Optibiome, soared by more than 2500% year-on-year, with Australia the latest market in its sights as part of its ambitious expansion plans.
Australia-based The Lupin Co has seen a five to six times increase in demand for products such as its prebiotic-rich lupin flakes, flours, protein bars and cereals over the past 12 weeks.
Meluka Australia, the subsidiary of ASX listed Eve Investment, has launched a new product – a Meluka honey and probiotic tonic – said to be the first-of-its-kind in the domestic market.
Just a single dose Undaria pinnatifida fucoidan (UPF) is able to affect gene expression related to fundamental cellular processes, an Australian study – believed to be the first of its kind – has shown.
Adelaide-based nutrition research company Trajan Nutrition is planning to commercialise a new dry blood spot (DBS) test for personalised nutrition companies.
Travel restriction put in place to stem the spread of COVID-19 has led to more than 30 overseas GMP inspections postponed, Australian regulator, the Therapeutic Goods Administration (TGA) has revealed.
The dietary supplement industry bodies in both Australia and New Zealand are seeking clarification that the sector is classed as an ‘essential service’, with both countries imposing movement restriction to curb the spread of COVID-19.
Gencor Pacific is embarking on a human trial in Australia to validate the immunity boosting ability of Palmitoylethanolamide (PEA) against the backdrop of the rising demand for immunity supplements amid the worldwide spread of COVID-19.
Swisse’s recent entry into India has been described as “the right time” since as the market conditions have ripen, with the the new venture marking a new milestone for the company which turns 50 this year, according to the company’s MD.